Abstract
This longitudinal study aimed at identifying predictors of community outcome from a broad range of neuropsychological, clinical psychopathologic, sociodemographic, and treatment related factors. N = 96 schizophrenia patients were assessed both at baseline during inpatient treatment and 1 year after discharge from hospital (follow-up). At follow-up functional outcome was measured by the Global Assessment of Functioning Scale (GAF) and the Social Adjustment Scale II (SAS II). Data were analyzed in an explorative way by means of multiple linear regression analyses. Three out of the five functional outcome measures were predicted by the negative syndrome and measures of cognitive functioning. However, the positive syndrome also consistently predicted psychosocial functioning. Altogether, the regression models explained between 20% and 35% of the variance in our outcome measures. The findings not only reemphasize that negative symptoms and cognitive dysfunctions are key determinants of community outcome but also point to a potential predictive relevance of positive symptoms.
Similar content being viewed by others
References
Addington J, Addington D (1999) Neurocognitive and social functioning in Schizophrenia. Schizophr Bull 25:172–182
Addington J, McCleary L, Munroe-Blum H (1998) Relationship between cognitive and social dysfunction in schizophrenia. Schizophr Res 34:59–66
Bach P, Hayes SC (2002) The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psychol 70:1129–1139
Bachmann S, Bottmer C, Essig M, Magnotta V, Schroder J (2007) Compliance with medication but not structural MRI measures predict functional outcome in first-episode schizophrenia patients. Schizophr Res 90:355–356
Breier A, Schreiber JL, Dyer J, Picker D (1991) National institute of mental health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 48:239–246
Buchkremer G, Klingberg S, Holle R, Schulze Mönking H, Hornung WP (1997) Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up. Acta Psychiatr Scand 96:483–491
Bustillo J, Lauriello J, Horan W, Keith S (2001) The psychosocial treatment of schizophrenia: an update. Am J Psychiatry 158:163–175
Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum, Hillsdale
Cohen J (1992) A power primer. Psychol Bull 112:155–159
Corrigan PW, Green MF, Toomey R (1994) Cognitive correlates to social cue perception in schizophrenia. Psychiatry Res 53:141–151
Davis JM (1974) Dose equivalence of the antipsychotic drugs. J Psychiatric Res 11:65–69
Dickerson F, Boronow JJ, Ringel N, Parente F (1996) Neurocognitive deficits and social functioning in outpatients with schizophrenia. Schizophr Res 21:75–83
Dickerson F, Boronow JJ, Ringel N, Parente F (1999) Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr Res 37:13–20
Erdfelder E, Faul F, Buchner A (1996) GPOWER: a general power analysis program. Behav Res Methods, Instrum Comput 28:1–11
Faul F, Erdfelder E (1992) GPOWER: a priori, post-hoc, and compromise power analyses for MS-DOS [Computer program; Version 2.0]. University of Bonn, Department of Psychology, Bonn (Germany)
Goldberg TE, Gold JM (1995) Neurocognitive deficits in schizophrenia. In: Hirsch S, Weinberger DR (eds) Schizophrenia. Blackwell Science, Oxford, pp 146–162
Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia. Am J Psychiatry 153:321–330
Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull 26:119–136
Green MF, Nuechterlein KH (1999) Should Schizophrenia be treated as a neurocognitive disorder? Schizophr Bull 25:309–318
Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72:41–51
Gumley A, O’Grady M, McNay L, Reilly J, Power K, Norrie J (2003) Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med 33:419–431
Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G (1993) Wisconsin card sorting test Manual, revised and expanded. Psychological Assessment Resources, Odessa, Florida
Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12:426–445
Herz MI, Lamberti S, Mintz J, Scott R, O’Dell SP, McCartan L, Nix G (2000) A program for relapse prevention in schizophrenia. A controlled study. Arch Gen Psychiatry 57:277–283
Heubrock D (1992) Der Auditiv-Verbale Lerntest (AVLT) in der klinischen und experimentellen Neuropsychologie. Durchführung, Auswertung und Forschungsergebnisse. Zeitschrift für Differentielle und Diagnostische Psychologie 3:161–174
Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC (1998) Two-year outcome in fist-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 155:1196–1201
Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G (2005) Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry 20:395–402
Hofer A, Baumgartner S, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA (2005) Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur Psychiatry 20:386–394
Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW (2006) Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci 256:246–255
Hogarty GE, Kornblith SJ, Greenwald D, DiBarry AL, Cooley S, Ulrich RF, Carter M, Flesher S (1997) Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: description of study and effects on relapse rates. Am J Psychiatry 154:1504–1513
Horn W (1983) Leistungsprüfsystem. LPS. Hogrefe, Göttingen
Ikebuchi E, Nakagome K, Tugawa R, Asada Y, Mori K, Takahashi N, Takazawa S, Ichikawa I, Akaho R (1996) What influences social skills in patients with schizophrenia? Preliminary study using the role play test, WAIS-R and event-related potential. Schizophr Res 22:143–150
Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow TJ (1990) Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry 157:182–189
Jones C, Cormac I, Silveira da Mota Neto J, Campbell C (2005) Cognitive behaviour therapy for schizophrenia (cochrane-Review), Vol 3. The Cochrane Library, Oxford
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276
Kemp R, Hayward P, Applewhaite G, Everitt B, David A (1996) Compliance therapy in psychotic patients: randomised controlled trial. BMJ 312:345–349
Kemp R, Kirov G, Everitt B, Hayward P, David A (1998) Randomised controlled trial of compliance therapy. 18-Month follow-up. Br J Psychiatry 172:413–419
Keshavan MS, Haas G, Miewald J, Montrose DM, Reddy R, Schooler NR, Sweeney JA (2003) Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull 29:757–769
Klingberg S, Wittorf A, Wiedemann G (2006) Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions? Eur Arch Psychiatry Clin Neurosci 256:532–540
Leary J, Johnstone EC, Owen DGC (1991) Social outcome. Br J Psychiatry 159(Suppl 13):13–20
Lehman AF, Goldberg R, Dixon LB, McNary S, Postrado L, Hackman A (2002) Improving employment outcomes for persons with severe mental illnesses. Arch Gen Psychiatry 59:165–172
Lehrl S (1992) Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B). Perimed-spitta, Nürnberg
Leung A, Chue P (2000) Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand 101:3–38
Lysaker PH, Bell MD, Bioty SM (1995) Cognitive deficits in schizophrenia. Prediction of symptom change for participators in work rehabilitation. J Nerv Ment Dis 183:332–336
Meyers JE, Meyers KR (1995) Rey complex figure test and recognition trial. Professional manual. Psychological Assessment Resources, Odessa, FL
Mueser KT (2000) Cognitive functioning, social adjustment, and longterm outcome in schizophrenia. In: Sharma T, Harvey P (eds) Cognition in schizophrenia. Oxford University Press, New York, pp 157–177
Müller P (1999) Therapie der Schizophrenie. Integrative Behandlung in Klinik, Praxis und Rehabilitation. Thieme, Stuttgart
Norman RM, Malla AK, Cortese L, Cheng S, Diaz K, McIntosh E (1999) Symptoms and cognition as predictors of community functioning. A prospective analysis. Am J Psychiatry 156:400–405
Nuechterlein KH, Asarnow RF (1996) Continuous Performance Test (CPT). Program for IBM_Compatible Microcomputers. Version 7.10, Los Angeles, CA
Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Martindale B, Orbach G, Morgan C (2002) Psychological treatments in schizophrenia: II. Meta-analysis of randomized controlled trials of social skills training and cognitive remediation. Psychol Med 32:783–791
Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C (2002) Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 32:763–782
Racenstein JM, Harrow M, Reed R, Martin E, Herbener E, Penn DL (2002) The relationship between positive symptoms and instrumental work functioning in schizophrenia: A 10 year follow-up study. Schizophr Res 56:95–103
Rector NA, Beck AT (2001) Cognitive behavioral therapy for schizophrenia: an empirical review. J Nerv Ment Dis 189:278–287
Reitan RM (1992) Trail making test. Reitan Neuropsychology Laboratory, South Tucson, Arizona
Rund BR (1983) The effect of distraction on focal attention in paranoid and non-paranoid schizophrenic patients compared to normals and non-psychotic psychiatric patients. J Psychiatr Res 17:241–250
Sass H, Wittchen HU, Zaudig M (1996) Diagnostisches und Statistisches Manual Psychischer Störungen—DSM IV. Übersetzt nach der vierten Auflage des Diagnostic and Statistical Manual of Mental Disorders der American Psychiatric Association. Hogrefe, Göttingen
Schooler NR, Hogarty GE, Weissman MM (1979) Social adjustment scale II (SAS II). In: Hargreaves WA (ed) Materials for community mental health program evaluators. US Department of Health & Human Services, Washington DC, pp 290–302
Silverstein ML, Zervick MJ (1985) Clinical psychopathologic symptoms in neuropsychologically impaired and intact schizophrenics. J Consult Clin Psychol 53:288–296
Simpson G, Angus J (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11–19
Tewes U (1994) HAWIE-R. Hamburg-Wechsler Intelligenztest für Erwachsene. Revision 1991. Huber, Bern, Stuttgart
Thornicroft G, Tansella M, Becker M, Knapp M, Leese M, Schene A (2004) The personal impact of schizophrenia in Europe. Schizophr Res 69:125–132
Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert SL, Miller AL (1997) The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res 25:21–31
Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR (2000) Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 57:907–913
Wittchen HU, Zaudig M, Fydrich T (1997) SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Hogrefe, Göttingen
Acknowledgments
This study was supported by the German Research Foundation (DFG), project number DFG Wi 1523/1-1, 1523/1-3, and Kl 1179/1-4 and by the research support program of the university hospital of Tuebingen (fortuene), project number 594-0-0 and 594-0-1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wittorf, A., Wiedemann, G., Buchkremer, G. et al. Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. Eur Arch Psychiatry Clin Neurosc 258, 48–58 (2007). https://doi.org/10.1007/s00406-007-0761-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-007-0761-z